By investigating the functional role of PCSK9 inhibitions in the metabolic targets, it could potentially lead to better understanding of the pathogenesis of myocardial infarction and ischemic stroke, as well as provide a potential therapeutic target for its management (11). This evidence concerns the gene PCSK9 and myocardial infarction.